| ID: | 170 | |
|---|---|---|
| Name: | Compound 170 | |
| Description: | Original numeration in publication: 10 | |
| Labels: | Training_set, Thiazolidine-2, 4-dione | |
| CAS: | ||
| InChi Code: | InChI=1S/C26H20ClN3O4S/c27-20-10-6-17(7-11-20)14-22-25(33)30(26(34)35-22)16-23(31)29-21-12-8-19(9-13-21)24(32)28-15-18-4-2-1-3-5-18/h1-14H,15-16H2,(H,28,32)(H,29,31)/b22-14- |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.7 |
El-Adl, K.; El-Helby, A.-G. A.; Sakr, H. a. A., R. R.; Mahdy, H. A.; Nasser, M. a. A., H. S.; El-Hddad, S. S. A. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2021, 354, e2000279. https://doi.org/10.1002/ardp.202000279 |
| 6.67039 |
Eq1: VEGFR-2 inhibition (Data used to train model) |